Skip to main content

Saturday, July 20:  All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.
Patients: click here for more information. Faculty/Staff: click here for information.

URMC / Medicine / Allergy, Immunology, and Rheumatology

Allergy, Immunology, and Rheumatology

  • Nelson Huertas in the Ritchlin Laboratory
  • AIR Fellows
  • Drs. Korman and Lieberman assist patient
  • Dr. John Looney presents at Lupus Education Day conference
  • Conference

Welcome from the Interim Chief

Jennifer Anolik, MD, PhDWelcome to the Division of Allergy, Immunology and Rheumatology (AIR). This Division has a long history of providing excellence in patient care, medical research, and education that dates back to the 1950’s. Our current faculty and staff are not only committed to carrying on this tradition but are also recognized nationally as leaders in their field.

We provide timely, comprehensive, individualized, state-of-the-art medical care to patients with musculoskeletal, autoimmune, and allergic diseases. We act as advocates for our patients and seek to improve treatments outcomes and quality of life.

Our faculty perform cutting edge investigation in basic science and translational research as we seek to expand our understanding of the mechanisms that underlie inflammatory, allergic and autoimmune disorders, with the goal of developing more effective and less toxic treatments.

We are also committed to educating the next generation of Allergists/Immunologists and Rheumatologists. Being a combined division with close ties to Pediatrics as well as many other Departments in the Medical Center including Orthopedics, Dermatology and others offers our fellows numerous unique opportunities.

Jennifer Anolik, M.D., Ph.D.
Interim Division Chief
Associate Chair of Research, Department of Medicine

Make an Appointment

Allergy & Immunology: (585) 486-0930

Rheumatology: (585) 486-0901


We now offer self-scheduling for follow-up appointments through MyChart, our online patient portal!

Upcoming Speakers and Events

AIR Combined Grand Rounds


Elisabeth Golden, MD
Assistant Professor of Neurology
University of Texas at Tyler

August 1, 2024

Rheumatology Grand Rounds

Monica Guma, MD, PhD
Professor, Department of Medicine
UC San Diego

September 12, 2024

Rheumatology Grand Rounds

Renuka Nayak, MD, PhD
Assistant Professor, Department of Medicine
UC San Francisco

October 3, 2024

Department of Medicine Grand Rounds: 6th Annual John J. Condemi Lectureship

Christopher Ritchlin, MD, MPH
Professor of Medicine, Division of Allergy, Immunology & Rheumatology
University of Rochester Medical Center

October 15, 2024

AIR Combined Grand Rounds

Sara McCoy, MD,PhD
Assistant Professor, Department of Medicine, Rheumatology Division
University of Wisconsin School of Medicine and Public Health

December 5, 2024

Department of Medicine Grand Rounds

Cheryl P. Rosario, DO, MPH
Assistant Professor of Medicine
Division of Allergy, Immunology & Rheumatology
University of Rochester Medical Center

January 21, 2025

Accelerating Medicine Partnerships Autoimmune & Immune-Mediated Disease Program

Division of Allergy, Immunology & Rheumatology researchers join NIH's Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) Program, a 5-year $58.5 million initiative to target new therapies for rheumatoid arthritis and psoriatic disease. Dr. Anolik will serve as principal lead for the RA team, while Dr. Ritchilin will lead the psoriasis/psoriatic arthritis team.

World Allergy Organization Center of Excellence

The University of Rochester is a World Allergy Center of Excellence, whose purpose is to intensify and accelerate multi-disciplinary scientific and clinical innovation, education, and advocacy worldwide, providing excellence in education, research, and training in Allergy, Asthma and Clinical Immunology.

Study from Jennifer Anolik, MD, PhD, and Team: Building a "Cellular Atlas" for Rheumatoid Arthritis

Darren Tabechian, MD

Darren Tabechian,

Javier Rangel-Moreno, PhD

Javier Rangel-
Moreno, PhD

Jennifer Anolik, MD, PhD

Jennifer Anolik,

New research from Jennifer Anolik, MD, PhD, Javier Rangel-Moreno, PhD and Darren Tabechian, MD along with several URMC and national/international collaborators, recently published in the journal Nature, deconstructed more than 314,000 cells into six major subtypes. In building this comprehensive atlas, understanding cell types and pathways, researchers can now use this knowledge in precision medicine, developing specific, individualized therapies. This work was funded by an NIH Network grant awarded to Anolik and team in 2014 that informed a new $10 million NIH grant for the Accelerating Medicines Partnership®: Autoimmune and Immune-Mediated Diseases (AMP AIM) program in 2022.